Emprendimiento e innovación en personas con discapacidad en Colombia: estudio de casos

Objetivo: Identificar las principales barreras y/o obstáculosque personas con discapacidad vencieron para lograr el emprendimiento.Metodología: Se desarrolló un estudio de caso medianteexperiencias de vida de tres sujetos que han logrado ser emprendedoresluego de sufrir una discapacidad. Se utilizó unenfoque cualitativo, mediante entrevista abierta, abordandocategorías de emprendimiento y discapacidad; desarrollandolos siguientes tópicos: factores sociales, individuales y motivacionales,barreras y limitaciones.Resultados y Conclusiones: Se encontró que los principalesfactores y/o motivaciones que llevan a una personacon discapacidad a ser emprendedor están: las creenciasreligiosas, la perseverancia, las redes sociales y familiares.Así mismo se encontró como característica en común la percepcióny análisis de la realidad desde una óptica emprendedora.En cuanto a las barreras y limitaciones se puedenresaltar la inequidad, la falta de oportunidad, escepticismoa la diversidad, barreras físicas, culturales y económicas, yfalta de políticas inclusivas

Search for dark matter produced in association with bottom or top quarks in √s = 13 TeV pp collisions with the ATLAS detector

A search for weakly interacting massive particle dark matter produced in association with bottom or top quarks is presented. Final states containing third-generation quarks and miss- ing transverse momentum are considered. The analysis uses 36.1 fb−1 of proton–proton collision data recorded by the ATLAS experiment at √s = 13 TeV in 2015 and 2016. No significant excess of events above the estimated backgrounds is observed. The results are in- terpreted in the framework of simplified models of spin-0 dark-matter mediators. For colour- neutral spin-0 mediators produced in association with top quarks and decaying into a pair of dark-matter particles, mediator masses below 50 GeV are excluded assuming a dark-matter candidate mass of 1 GeV and unitary couplings. For scalar and pseudoscalar mediators produced in association with bottom quarks, the search sets limits on the production cross- section of 300 times the predicted rate for mediators with masses between 10 and 50 GeV and assuming a dark-matter mass of 1 GeV and unitary coupling. Constraints on colour- charged scalar simplified models are also presented. Assuming a dark-matter particle mass of 35 GeV, mediator particles with mass below 1.1 TeV are excluded for couplings yielding a dark-matter relic density consistent with measurements

Emprendimiento e innovación en personas con discapacidad en Colombia: estudio de casos

Objetivo: Identificar las principales barreras y/o obstáculosque personas con discapacidad vencieron para lograr el emprendimiento.Metodología: Se desarrolló un estudio de caso medianteexperiencias de vida de tres sujetos que han logrado ser emprendedoresluego de sufrir una discapacidad. Se utilizó unenfoque cualitativo, mediante entrevista abierta, abordandocategorías de emprendimiento y discapacidad; desarrollandolos siguientes tópicos: factores sociales, individuales y motivacionales,barreras y limitaciones.Resultados y Conclusiones: Se encontró que los principalesfactores y/o motivaciones que llevan a una personacon discapacidad a ser emprendedor están: las creenciasreligiosas, la perseverancia, las redes sociales y familiares.Así mismo se encontró como característica en común la percepcióny análisis de la realidad desde una óptica emprendedora.En cuanto a las barreras y limitaciones se puedenresaltar la inequidad, la falta de oportunidad, escepticismoa la diversidad, barreras físicas, culturales y económicas, yfalta de políticas inclusivas

Entrepreneurship and innovation related to disabled people in Colombia: case study

Objetivo: Identificar las principales barreras y/o obstáculos que personas con discapacidad vencieron para lograr el emprendimiento. Metodología: Se desarrolló un estudio de caso mediante experiencias de vida de tres sujetos que han logrado ser emprendedores luego de sufrir una discapacidad. Se utilizó un enfoque cualitativo, mediante entrevista abierta, abordando categorías de emprendimiento y discapacidad; desarrollando los siguientes tópicos: factores sociales, individuales y motivacionales, barreras y limitaciones. Resultados y Conclusiones: Se encontró que los principales factores y/o motivaciones que llevan a una persona con discapacidad a ser emprendedor están: las creencias religiosas, la perseverancia, las redes sociales y familiares. Así mismo se encontró como característica en común la percepción y análisis de la realidad desde una óptica emprendedora. En cuanto a las barreras y limitaciones se pueden resaltar la inequidad, la falta de oportunidad, escepticismo a la diversidad, barreras físicas, culturales y económicas, y falta de políticas inclusivas.Objective: To identify the main barriers or obstacles that disabled individuals overcome to achieve entrepreneurship. Methodology: We developed a case study using life experiences of three subjects who have managed to be entrepreneurs after suffering a disability. We used a qualitative approach, through open interview, addressing categories of entrepreneurship and disability; developing the following topics: social, individual, and motivational factors, barriers and limitations. Results and Conclusion: Our results indicate that the main factors or motivations that lead a person with a disability to be entrepreneur are: religious beliefs, the perseverance, and the social and family networks. Also found as characteristic in common perception and analysis of the situation from an entrepreneurial perspective. As barriers and limitations can be highlighted: inequality, lack of opportunity, skepticism to diversity, physical, cultural and economic barriers, and lack of inclusive policies

Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

Background Anastomotic leak affects 8 per cent of patients after right colectomy with a 10-fold increased risk of postoperative death. The EAGLE study aimed to develop and test whether an international, standardized quality improvement intervention could reduce anastomotic leaks. Methods The internationally intended protocol, iteratively co-developed by a multistage Delphi process, comprised an online educational module introducing risk stratification, an intraoperative checklist, and harmonized surgical techniques. Clusters (hospital teams) were randomized to one of three arms with varied sequences of intervention/data collection by a derived stepped-wedge batch design (at least 18 hospital teams per batch). Patients were blinded to the study allocation. Low- and middle-income country enrolment was encouraged. The primary outcome (assessed by intention to treat) was anastomotic leak rate, and subgroup analyses by module completion (at least 80 per cent of surgeons, high engagement; less than 50 per cent, low engagement) were preplanned. Results A total 355 hospital teams registered, with 332 from 64 countries (39.2 per cent low and middle income) included in the final analysis. The online modules were completed by half of the surgeons (2143 of 4411). The primary analysis included 3039 of the 3268 patients recruited (206 patients had no anastomosis and 23 were lost to follow-up), with anastomotic leaks arising before and after the intervention in 10.1 and 9.6 per cent respectively (adjusted OR 0.87, 95 per cent c.i. 0.59 to 1.30; P = 0.498). The proportion of surgeons completing the educational modules was an influence: the leak rate decreased from 12.2 per cent (61 of 500) before intervention to 5.1 per cent (24 of 473) after intervention in high-engagement centres (adjusted OR 0.36, 0.20 to 0.64; P < 0.001), but this was not observed in low-engagement hospitals (8.3 per cent (59 of 714) and 13.8 per cent (61 of 443) respectively; adjusted OR 2.09, 1.31 to 3.31). Conclusion Completion of globally available digital training by engaged teams can alter anastomotic leak rates. Registration number: NCT04270721 (http://www.clinicaltrials.gov)